English | Español
 






Important Information about MIRAPEX: MIRAPEX® (pramipexole dihydrochloride) Tablets are indicated for the treatment of the signs and symptoms of idiopathic Parkinson’s disease.

Patients have reported falling asleep without any warning signs during activities of daily living, including operation of a motor vehicle, which sometimes resulted in accidents. Hallucinations and dizziness upon standing may occur.

The most commonly reported adverse events in early and late disease in clinical trials were dizziness, involuntary movement, hallucinations, headache, difficulty falling asleep, sleepiness and nausea.

Patients and caregivers should be informed that impulse control disorders/compulsive behaviors may occur while taking medicines, including pramipexole, to treat Parkinson's disease.

Please see full Prescribing Information.

This information is intended for US residents only.

Copyright © 2007 Boehringer Ingelheim Pharmaceuticals, Inc. All rights reserved.
Use of this site is subject to the Internet Site Legal Notices and Disclaimers and Privacy Policy.